Accelerate Diagnostics (AXDX) Reports In-Line Q3 EPS

Accelerate Diagnostics (NASDAQ: AXDX) reported Q3 EPS of ($0.41), in-line with the analyst estimate of ($0.41). Revenue for the quarter came in at $1.36 million versus the consensus estimate of $2.95 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Casey's General Stores (CASY) PT Lowered to $720 at UBS on Peak Fuel Margin Concerns
• Signet Jewelers (SIG) PT Raised to $136 at UBS on Strong Growth Prospects